196 related articles for article (PubMed ID: 30679687)
1. Impaired activation of lesional CD8
Mukherjee S; Sengupta R; Mukhopadhyay D; Braun C; Mitra S; Roy S; Kanti Das N; Chatterjee U; von Stebut E; Chatterjee M
Sci Rep; 2019 Jan; 9(1):762. PubMed ID: 30679687
[TBL] [Abstract][Full Text] [Related]
2. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
[TBL] [Abstract][Full Text] [Related]
4. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
[TBL] [Abstract][Full Text] [Related]
5. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
[TBL] [Abstract][Full Text] [Related]
6. Does immune dysregulation contribute towards development of hypopigmentation in Indian post kala-azar dermal leishmaniasis?
Sengupta R; Mitra S; Dighal A; Moulik S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
Exp Dermatol; 2023 Jun; 32(6):740-751. PubMed ID: 36760064
[TBL] [Abstract][Full Text] [Related]
7. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
[TBL] [Abstract][Full Text] [Related]
8. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
[TBL] [Abstract][Full Text] [Related]
10. Status of B-Lymphocyte Subsets and Their Homing Markers in Patients With Post-Kala-Azar Dermal Leishmaniasis.
Sengupta S; Goswami D; Chakraborty B; Chaudhuri SJ; Ghosh MK; Chatterjee M
Parasite Immunol; 2024 Mar; 46(3):e13031. PubMed ID: 38527908
[TBL] [Abstract][Full Text] [Related]
11. Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
[TBL] [Abstract][Full Text] [Related]
13. Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.
Mukherjee S; Mukhopadhyay D; Braun C; Barbhuiya JN; Das NK; Chatterjee U; von Stebut E; Chatterjee M
Exp Dermatol; 2015 Mar; 24(3):232-4. PubMed ID: 25580856
[TBL] [Abstract][Full Text] [Related]
14. The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.
Jafarzadeh A; Jafarzadeh S; Sharifi I; Aminizadeh N; Nozari P; Nemati M
Cytokine; 2021 Nov; 147():155321. PubMed ID: 33039255
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study.
Verma N; Bimal S; Das VN; Pandey K; Singh D; Lal CS; Singh AK; Sinha PK; Das P
Biomed Res Int; 2015; 2015():745062. PubMed ID: 26090441
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis.
Singh AK; Das VNR; Amit A; Dikhit MR; Mahantesh V; Singh SK; Naryan S; Pandey K; Das P; Verma N; Bimal S
J Cell Biochem; 2018 Sep; 119(9):7406-7418. PubMed ID: 29775225
[TBL] [Abstract][Full Text] [Related]
17. M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis.
Mukhopadhyay D; Mukherjee S; Roy S; Dalton JE; Kundu S; Sarkar A; Das NK; Kaye PM; Chatterjee M
PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004145. PubMed ID: 26496711
[TBL] [Abstract][Full Text] [Related]
18. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
[TBL] [Abstract][Full Text] [Related]
20. Iron trafficking in patients with Indian Post kala-azar dermal leishmaniasis.
Dighal A; Mukhopadhyay D; Sengupta R; Moulik S; Mukherjee S; Roy S; Chaudhuri SJ; Das NK; Chatterjee M
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007991. PubMed ID: 32023254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
